Effects of converting enzyme inhibitor on hepatic blood flow in man
- 31 May 1984
- journal article
- Published by Elsevier in The American Journal of Medicine
- Vol. 76 (5) , 62-65
- https://doi.org/10.1016/0002-9343(84)90886-6
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- CaptoprilNew England Journal of Medicine, 1982
- Captopril Attenuates Adrenergic Vasoconstriction in Rat Mesenteric Arteries by Angiotensin-Dependent and -Independent MechanismsClinical Science, 1981
- EFFECTS OF MECLOFENAMATE AND CAPTOPRIL ON BLOOD FLOW TO THE KIDNEY AND SPLEEN IN CONSCIOUS RABBITS SUBJECTED TO MILD HAEMORRHAGEClinical and Experimental Pharmacology and Physiology, 1981
- Angiotensin inhibition in severe heart failure: Acute central and limb hemodynamic effects of captopril with observations on sustained oral therapyAmerican Heart Journal, 1981
- HAEMODYNAMIC, HORMONAL, AND ELECTROLYTE RESPONSES TO CAPTOPRIL IN RESISTANT HEART FAILUREThe Lancet, 1980
- LOW-DOSE CAPTOPRIL IN CHRONIC HEART FAILURE: ACUTE HAEMODYNAMIC EFFECTS AND LONG-TERM TREATMENTThe Lancet, 1980
- Central and peripheral hemodynamic effects of angiotensin inhibition in patients with refractory congestive heart failure.Circulation, 1980
- Constrasts and similarities of acute hemodynamic responses to specific antagonism of angiotensin II ([Sar1, Thr8] A II) and to inhibition of converting enzyme (captopril).Circulation, 1980
- Essential hypertension: effect of an oral inhibitor of angiotensin-converting enzyme.BMJ, 1979
- Differences in Direct Effects of Adrenergic Stimuli on Coronary, Cutaneous, and Muscular VesselsJournal of Clinical Investigation, 1972